GMP and Other Discussion for Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited IPOAbout Arvee Laboratories (India) Limited

Arvee Laboratories (India) Limited provides specialty chemicals in India. The company provides polymer modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, including 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid. The company also exports its products. Arvee Laboratories (India) Limited was incorporated in 2012 and is based in Ahmedabad, India.

Your Comment:
 4 + 3 

Jay Feb 10 2018 12:19:19 PM
IPO proceeds used like Public se lo aur apne pocket me dallo, stated in prospectus that repayment of unsecured loan of promoters... I think not worthy to apply.